Reporter brief
Metformin effects on prostate cancer biology tested in randomized controlled trial
What happened
The METAL study was a randomized, placebo-controlled, double-blind window of opportunity trial examining metformin's biological effects in localized prostate cancer. No results, effect sizes, or sample size details were reported in the available material.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Patients with localised prostate cancer
- Design
- Rct
- Sample
- —
- Journal
- Guy's and St Thomas' NHS Foundation Trust
- Published
- Jul 30, 2015
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Metformin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.